2018
DOI: 10.1016/j.jdcr.2017.08.005
|View full text |Cite
|
Sign up to set email alerts
|

Successful treatment of mucous membrane pemphigoid with bortezomib

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(3 citation statements)
references
References 10 publications
0
3
0
Order By: Relevance
“…4 Bortezomib has been used for recalcitrant cases. 5 These therapies carry significant adverse effects and costs. Cyclophosphamide has gastrointestinal effects, causes cytopenia requiring close monitoring, and has a long-term cancer risk.…”
Section: Discussionmentioning
confidence: 99%
“…4 Bortezomib has been used for recalcitrant cases. 5 These therapies carry significant adverse effects and costs. Cyclophosphamide has gastrointestinal effects, causes cytopenia requiring close monitoring, and has a long-term cancer risk.…”
Section: Discussionmentioning
confidence: 99%
“…Approximately 1.77 billion people globally, use pit latrines as a main source of sanitation (Graham and Polizzotto, 2013) and there is growing concern that the release of unsanitary chemicals and microbial contaminants from these pit latrines affects human health and can contaminate ground water (Graham and Polizzotto, 2013). Similarly, conventional flush latrines, if not flushed quickly enough, will emit odours and aerosols into the bathroom environment, in particular if there is no proper ventilation in the bathroom or toilet structure themselves (Saeed et al, 2018;Abney et al, 2021). These odours and pathogen-carrying aerosols can then enter other parts of a building through open doors (Nakagiri et al, 2015;Abney et al, 2021).…”
Section: Malodours and The Effects From Regular Flush And Septic Tank...mentioning
confidence: 99%
“…It might represent a powerful tool to specifically eliminate long-lived PCs, which to some extent resemble myeloma cells concerning their metabolism [235]. Positive effects have been postulated in numerous autoimmune diseases such as experimental myasthenia gravis [236], SLE [237] and primary Sjögren's syndrome [238], a case report describes the successful use in mucous membrane pemphigoid [239]. Another interesting approach is the attempt to selectively inhibit the so called "immunoproteasome", the first in-class molecule KZR-616 is under clinical investigation for therapy of dermatomyositis (NCT04033926) and has already been used to treat SLE patients in early clinical trials [167].…”
Section: Proteasome Inhibitors/immunoproteasome Inhibitorsmentioning
confidence: 99%